Barr, Lilly settle suit
-
- June
- 4
Barr Pharmaceuticals Inc. and Eli Lilly & Co. have settled a patent dispute involving a weekly-dosage version of the anti-depression medication, Prozac, Barr announced today.
The parties voluntarily dismissed all claims and counterclaims in the patent litigation Friday, said Barr, who’s Pomona-based Barr Laboratories Inc. unit was sued by Eli Lilly in May 2006. Barr still needs Food and Drug Administration approval to sell its 90-milligram version of the drug, Prozac Weekly, which had sales of approximately $30 million in the year ending March, based on industry data, Barr said.
This entry was posted
on Monday, June 4th, 2007 at 5:41 pm by David Schepp.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: In the courts
Print
| 
Email
